The Major Change That Every Metastatic Breast Cancer Patient Should Get Tested For — SurvivorNet Advisor Dr. Elizabeth Comen Takes The Message To TV

Updated September 26th, 2023

The Major Change That Every Metastatic Breast Cancer Patient Should Get Tested For — SurvivorNet Advisor Dr. Elizabeth Comen Takes The Message To TV

NOW
PLAYING
HER2-Low Breast Cancers: Are Patients Being Reclassified and Getting Life-Changing Treatments? Major Cancer Centers Say Yes
NOW
PLAYING
HER2-Low Metastatic Breast Cancers Can Benefit From Enhertu
NOW
PLAYING
Real-World Implications Of Her2 Low- The Major New Breast Cancer Designation And Its Treatment — How Low Is Too Low?
NOW
PLAYING
FDA Approves Diagnostic Test to Identify Patients with Metastatic Breast Cancer Expressing Low Levels of HER2
NOW
PLAYING
Is Your Breast Cancer HER2 Negative? How To Get Tested For A New Drug That Prolongs Life
NOW
PLAYING
What is HER2 Classification of Breast Cancer?

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.